Ruvy Rose Dayrit Kutilek, NP

Ruvy Rose Kutilek practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Ruvy Rose Kutilek's NPI, 1184207771, was assigned on April 30, 2021. Ruvy Rose Kutilek holds California license 95015661.

Ruvy Rose Kutilek's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Ruvy Rose Kutilek's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Ruvy Rose Kutilek practices. Vendor and product names are available with a free account.

Acute care is Ruvy Rose Kutilek's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Ruvy Rose Kutilek is licensed in California.

CMS counts 63 Medicare patients who saw Ruvy Rose Kutilek in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ruvy Rose Kutilek's median patient age at 63, with 52% women.

In 2024, Ruvy Rose Kutilek wrote 448 Medicare Part D claims for 59 patients. 74% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Ruvy Rose Kutilek for performance year 2024, reported as part of a group. Ruvy Rose Kutilek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Ruvy Rose Kutilek from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $135.